FLT1 and colorectal carcinoma: A series of loss-of-function, genetic null and VEGFR inhibitor assays further confirmed that VEGFR1 is a positive regulator of WNT signaling that functions in a GSK3B-independent manner [61], making it an attractive target in those CRC tumors where APC function is lost.